Key facts
- This page summarizes Christopher J. Twomey's Form 4 filing for TANDEM DIABETES CARE INC (TNDM).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 24 May 2024, 19:22.
Christopher J. Twomey - 22 May 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)
- Reporting relationship
- Director
- Issuer ticker
- TNDM
- Reported as of
- 22 May 2024
- Net transaction value
- +$229,371
- SEC form
- 4
- Accepted by SEC
- 24 May 2024, 19:22:45 UTC
- Prior SEC filing
- 16 Jun 2023
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rachel Malina, Attorney-in-Fact for Christopher J. Twomey
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher J. Twomey filed Form 4 for TANDEM DIABETES CARE INC (TNDM) on 24 May 2024.
Change
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: +$229,371.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TNDM
transaction
Common Stock
Options Exercise
- Transaction value
- $229,371
- Shares
- +4,434
- Change %
- +65%
- Price
- $51.73
- Shares after
- 11,288
- Date
- 24 May 2024
- Ownership
- Direct
TNDM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,112
- Date
- 22 May 2024
- Ownership
- See Footnote
- Footnotes
- F1
TNDM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,568
- Date
- 22 May 2024
- Ownership
- See Footnotes
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNDM
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +4,387
- Change %
- Price
- $0.000000
- Shares after
- 4,387
- Date
- 22 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,387
- Exercise price
- Footnotes
- F3, F4, F5
TNDM
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -4,434
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 24 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,434
- Exercise price
- Footnotes
- F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.
Footnote F2
The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over these securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.
Footnote F3
Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
Footnote F4
Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
Footnote F5
RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
Footnote F6
Awarded on May 24, 2023 pursuant to the 2023 Plan.